Topic: Capacity Building

Dr. Peter Hotez emphasizes that the primary barrier to global vaccine distribution is "human capital" and the technical knowledge required for quality control, rather than patent restrictions. He notes the lack of vaccine manufacturing capacity on the African continent and in Latin America. The focus remains on building long-term infrastructure to produce low-cost, durable vaccines for resource-poor countries.